These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9055038)
41. Study of phosphorothioate-modified oligonucleotide resistance to 3'-exonuclease using capillary electrophoresis. Gilar M; Belenky A; Budman Y; Smisek DL; Cohen AS J Chromatogr B Biomed Sci Appl; 1998 Aug; 714(1):13-20. PubMed ID: 9746230 [TBL] [Abstract][Full Text] [Related]
42. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides. Galderisi U; Di Bernardo G; Melone MA; Galano G; Cascino A; Giordano A; Cipollaro M J Cell Biochem; 1999 Jul; 74(1):31-7. PubMed ID: 10381259 [TBL] [Abstract][Full Text] [Related]
43. The influence of oligodeoxyribonucleotide phosphorothioate pyrimidine strands on triplex stability. Tsukahara S; Kim SG; Takaku H Nucleic Acids Symp Ser; 1992; (27):121-2. PubMed ID: 1289787 [TBL] [Abstract][Full Text] [Related]
44. Activity of acid deoxyribonuclease towards diastereoisomers of thymidyl 3'-(4-nitrophenyl phosphorothioate). Stereochemistry of transnucleotidylation reaction. Uznanski B; Niewiarowski W; Stec WJ J Biol Chem; 1986 Jan; 261(2):592-8. PubMed ID: 3941094 [TBL] [Abstract][Full Text] [Related]
45. Phosphorothioate-containing RNAs show mRNA activity in the prokaryotic translation systems in vitro. Ueda T; Tohda H; Chikazumi N; Eckstein F; Watanabe K Nucleic Acids Res; 1991 Feb; 19(3):547-52. PubMed ID: 2011526 [TBL] [Abstract][Full Text] [Related]
46. Substrate specificity and stereospecificity of calf spleen phosphodiesterase towards deoxyribonucleosidyl 3'-(4-nitrophenyl phosphates) and phosphorothioates. Niewiarowski W; Uznanski B Eur J Biochem; 1985 Nov; 153(1):145-53. PubMed ID: 2998790 [TBL] [Abstract][Full Text] [Related]
47. Spectroscopic evidence for the formation of four-stranded solution structure of oligodeoxycytidine phosphorothioate. Kanehara H; Mizuguchi M; Tajima K; Kanaori K; Makino K Biochemistry; 1997 Feb; 36(7):1790-7. PubMed ID: 9048563 [TBL] [Abstract][Full Text] [Related]
48. Analysis of oligo(deoxynucleoside phosphorothioate)s and their diastereomeric composition. Wilk A; Stec WJ Nucleic Acids Res; 1995 Feb; 23(3):530-4. PubMed ID: 7885850 [TBL] [Abstract][Full Text] [Related]
49. Retention of configuration in the action of human plasma 3'-exonuclease on oligo(deoxynucleoside phosphorothioate). A new method for assignment of absolute configuration at phosphorus in isotopomeric deoxyadenosine 5'-O-[(18)O]phosphorothioate. Koziołkiewicz M; Owczarek A; Wójcik M; Domański K; Guga P; Stec WJ J Am Chem Soc; 2002 May; 124(17):4623-7. PubMed ID: 11971710 [TBL] [Abstract][Full Text] [Related]
50. Effect of the extent of thiolation and introduction of phosphorothioate internucleotide linkages on the anti-HIV activity of Suligovir [(s4dU)35]. Horváth A; Beck Z; Bardos TJ; Dunn JA; Aradi J Bioorg Med Chem Lett; 2006 Oct; 16(20):5321-3. PubMed ID: 16920358 [TBL] [Abstract][Full Text] [Related]
51. A semi-empirical Hückel molecular orbital analysis of internucleotide phosphorothioate diesters. Weltman JK; Karim AS Anticancer Res; 1998; 18(4A):2733-6. PubMed ID: 9703937 [TBL] [Abstract][Full Text] [Related]
53. [Reactive derivatives of oligonucleotide phosphorothioate analogs. I. Selective activation of terminal phosphates and preparation of phosphamide derivatives of oligonucleotide phosphorothioate analogs]. Amirkhanov NV; Zarytova VF Bioorg Khim; 1995 May; 21(5):365-75. PubMed ID: 7661862 [TBL] [Abstract][Full Text] [Related]
54. Diastereomers of 5'-O-adenosyl 3'-O-uridyl phosphorothioate: chemical synthesis and enzymatic properties. Burgers PM; Eckstein F Biochemistry; 1979 Feb; 18(4):592-6. PubMed ID: 217419 [TBL] [Abstract][Full Text] [Related]
55. Synthesis and selective cleavage of an oligodeoxynucleotide containing a bridged internucleotide 5'-phosphorothioate linkage. Mag M; Lüking S; Engels JW Nucleic Acids Res; 1991 Apr; 19(7):1437-41. PubMed ID: 2027751 [TBL] [Abstract][Full Text] [Related]
56. The role of the Hint1 protein in the metabolism of phosphorothioate oligonucleotides drugs and prodrugs, and the release of H Krakowiak A; Piotrzkowska D; Kocoń-Rębowska B; Kaczmarek R; Maciaszek A Biochem Pharmacol; 2019 May; 163():250-259. PubMed ID: 30772266 [TBL] [Abstract][Full Text] [Related]
57. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines. Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928 [TBL] [Abstract][Full Text] [Related]
58. Stereocontrolled phosphorothioate synthesis using chiral phosphite triesters. Mizuguchi M; Yomogida Y; Makino K Nucleic Acids Symp Ser; 1995; (34):113-4. PubMed ID: 8841578 [TBL] [Abstract][Full Text] [Related]
59. Absolute configuration of the diastereomers of adenosine 5'-O-(1-thiotriphosphate): consequences for the stereochemistry of polymerization by DNA-dependent RNA polymerase from Escherichia coli. Burgers PM; Eckstein F Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4798-800. PubMed ID: 368798 [TBL] [Abstract][Full Text] [Related]
60. Phosphorothioate and normal oligodeoxyribonucleotides with 5'-linked acridine: characterization and preliminary kinetics of cellular uptake. Stein CA; Mori K; Loke SL; Subasinghe C; Shinozuka K; Cohen JS; Neckers LM Gene; 1988 Dec; 72(1-2):333-41. PubMed ID: 2854090 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]